哈尔滨三联药业股份有限公司关于全资子公司获得政府补助的公告

Group 1 - The company’s wholly-owned subsidiary, Lanxi Hasi Pharmaceutical Co., Ltd., received a government subsidy of 6 million yuan, which accounts for 10.23% of the company's most recent audited net profit attributable to shareholders [1][2] - The subsidy is classified as a revenue-related government grant, which is expected to positively impact the company's operating performance by increasing the total profit for the year 2026 by 6 million yuan [2] Group 2 - The company assures that the information disclosed is true, accurate, and complete, with no false records or misleading statements [1] - Relevant documents regarding the subsidy, including government approval documents and payment receipts, will be kept on file for reference [4]